AbbVie Inc. insider buying and selling
4 Form 4 filings against AbbVie Inc. (ABBV) in the last 90 days. Below are the transactions from 4 recent filings, one per insider where the window allows, as filed.
| Date | Insider and role | Transaction | Code | Shares | Price | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-16 | SALEKI AZITAEVP, CHIEF OPERATIONS OFFICER | option exercise | M | 23,935 | $61.36 | 221,729 |
| 2026-11-16 | SALEKI AZITAEVP, CHIEF OPERATIONS OFFICER | tax withholding | F | 13,481 | $298.55 | 208,248 |
| 2026-11-12 | Stewart Jeffrey RyanEVP, CHIEF COMMERCIAL OFFICER | gift | G | 3,450 | 79,721 | |
| 2026-11-09 | Stewart Jeffrey RyanEVP, CHIEF COMMERCIAL OFFICER | option exercise | M | 16,070 | $114.36 | 99,241 |
| 2026-11-09 | Stewart Jeffrey RyanEVP, CHIEF COMMERCIAL OFFICER | option exercise | M | 24,549 | $93.50 | 123,790 |
| 2026-11-09 | Stewart Jeffrey RyanEVP, CHIEF COMMERCIAL OFFICER | open-market sale | S | 40,619 | $293.60 | 83,171 |
What the filings show
Across the 4 filings read here, 2 insiders at AbbVie Inc. (ABBV) filed; 1 of them traded on the open market and reported 1 open-market sale of 40,619 shares worth about $11.9M.
The largest by value was Stewart Jeffrey Ryan (EVP, CHIEF COMMERCIAL OFFICER), with about $11.9M sold on the open market.
The Form 4 flow against AbbVie Inc., parsed and explained
The free view above is the newest few filings. The paid report reads the newest Form 4 filings of the last 90 days (up to 100), separates open-market buys and sales from awards, exercises and tax withholding, totals the flow per insider, flags 10b5-1 plans where the filing notes them, and hands you a cited write-up plus a downloadable transactions table.
Generated from public SEC EDGAR filings. Filing data is shown as filed. This is information, not investment advice.